Tylenol maker admits to selling medicine contaminated with metal
McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, reached a $25 million settlement with the Department of Justice on Tuesday. The Tylenol maker pleaded guilty to selling liquid medicines that were contaminated with metal.
In 2010, the company recalled medicines including Infants' Tylenol and Childrens' Motrin. Reuters reports that the issues began in 2009, when a customer reported "black specks" in Infants' Tylenol, and the specks turned out to be nickel and chromium. The liquid medicines that were contaminated with metal often had "moldy odors," too, Reuters notes.
The agreement also included furthering safety measures at McNeil's Fort Washington facility before it reopens.
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
